- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Telehealth: A tool for the moment or the new normal?
Author(s):
In this webinar, moderated by Daniel Siegel, M.D., M.A., FAAD, FACMS, experts discuss guidance on the use of teledermatology and ways to successfully implement new models of care during the COVID-19 pandemic.
The threat from COVID-19 has forced physicians to find new ways to operate. While teledermatology has been around for years, relaxed regulations have expanded its application and may be easing the transition to virtual care. Or are they?
In this webinar, moderated by Daniel Siegel, M.D., M.A., FAAD, FACMS, clinical professor of dermatology, SUNY Downstate in Brooklyn, New York, you'll hear your peers discuss what has changed, how it’s changing, and ways to successfully implement new models of care.
Here's what you'll learn:
- Current guidance on the use of teledermatology
- Methods for delivering teledermatology and how to set up an ideal workflow
- How reimbursements work
- How to comply with teledermatology regulations
Panelists include:
- Carrie Kovarik, M.D., associate professor of dermatology, dermatopathology, and infectious diseases, University of Pennsylvania
- Orit Markowitz, M.D., associate professor of dermatology, the Icahn School of Medicine at Mount Sinai
- Brad Glick, D.O., MPH, FAOCD, FAAD, director of the dermatology residency at the Larkin Hospital, clinical assistant professor of dermatology, Herbert Wertheim College of Medicine
